Eyal Miller MBA, MA

I serve as an advisor and non executive board member for companies that need to turn excellent science into a real, scalable business.

I bring more than 25 years across medtech, diagnostics and digital health, leading commercial strategy, global launches and fundraising on five continents. Most recently, as CEO of Identifai Genetics, I have been building an AI and whole genome sequencing platform in prenatal genetics, working with leading hospitals, CLIA labs, regulators and top tier investors. I am very comfortable in the details of clinical validation, reimbursement strategy, regulatory pathways, as well as in boardrooms where hard capital allocation and go to market decisions are made.

Where I add the most value is to companies that sit at the intersection of medical devices, diagnostics and data, that want to enter new markets or prepare for a significant funding round or exit. I help management teams sharpen their strategy, focus on the right KPIs, structure partnerships with global labs and industry leaders, and communicate a clear story to investors and the board.

If you are a growth stage medtech or diagnostic company in Europe or the Middle East, especially in imaging, genomics, liquid biopsy, Gynecology and women%27s health or AI driven decision support, and you need someone who has actually done global launches, complex partnerships and tough fundraising in this space, this is where I can be a very effective advisor or board member.